Euprolactinemic galactorrhea with escitalopram

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 26, Issue 3, 2014, Pages

  Praharaj, Samir Kumar ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; ESCITALOPRAM; PROLACTIN; ANTIDEPRESSANT AGENT; CITALOPRAM;

ADULT; ANXIETY DISORDER; BREAST DISCHARGE; CASE REPORT; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GALACTORRHEA; HUMAN; LETTER; PANIC; PATIENT REFERRAL; PRESCRIPTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TREATMENT DURATION; ANXIETY DISORDERS; BLOOD; CHEMICALLY INDUCED; YOUNG ADULT;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; CITALOPRAM; FEMALE; GALACTORRHEA; HUMANS; PROLACTIN; YOUNG ADULT;

EID: 84905699974     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.13070147     Document Type: Letter

References (16)

1. Bareggi SR, Mundo E, Dell'Osso B, et al: The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opin Drug Metab Toxicol 2007; 3:741-753
2. Dhillon S, Scott LJ, Plosker GL: Escitalopram: a review of its use in the management of anxiety disorders. CNS Drugs 2006; 20:763-790
3. Hall MJ: Breast tenderness and enlargement induced by sertraline. Am J Psychiatry 1994; 151:1395-1396
4. Bronzo MR, Stahl SM: Galactorrhea induced by sertraline. Am J Psychiatry 1993; 150:1269-1270
5. Nebhinani N: Sertraline-induced galactorrhea: case report and review of cases reported with other SSRIs. Gen Hosp Psychiatry 2013; 35:e3-e5
6. Peterson MC: Reversible galactorrhea and prolactin elevation related to fluoxetine use. Mayo Clin Proc 2001; 76:215-216
7. Gulsun M, Evrensel A, Verim S: Galactorrhea during escitalopram treatment: a case report. Bull Clin Psychopharmacol 2006; 16:39-41
8. Aggarwal A, Kumar R, Sharma RC, et al: Escitalopram induced galactorrhoea: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34:557-558
9. Shim SH, Lee YJ, Lee EC: A case of galactorrhea associated with excitalopram. Psychiatry Investig 2009; 6:230-232
10. Spigset O, Mjorndal T: The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol 1997; 17:292-297
11. Pratheesh PJ, Praharaj SK, Srivastava A: Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination. Psychopharmacol Bull 2011; 44: 70-73
12. Damsa C, Bumb A, Bianchi-Demicheli F, et al: "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry 2004; 65:1064-1068
13. Belli H, Vardar MK, Yesilyurt S, et al: Citalopram related euprolactinaemic galactorrhoea: a case report. West Indian Med J 2010; 59:100-101
14. Mahasuar R, Majhi P, Ravan JR: Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman. Gen Hosp Psychiatry 2010; 32: 341. e11-3
15. Gulsun M, Algul A, Semiz UB, et al: A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med 2007; 37:275-278
16. Ataya KM, Subramanian MG, Lawson DM, et al: Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone. J Reprod Med 1996; 41:156-160